Rainbow Children's Medicare Q4 FY26 Earnings Call Transcript Released
Rainbow Children's Medicare released its Q4 & FY26 earnings call transcript. FY26 saw record capacity addition of 500 beds and 20% YoY revenue growth. Q4 FY26 revenue grew 24% to ₹459.9 crore, with PAT up 38% to ₹78.2 crore. FY26 revenue was ₹1,703 crore. The company has a strong liquidity of ₹594 crore and no debt, funding expansion through internal accruals.
The announcement includes detailed financial results, significant capacity expansion plans, and strategic growth initiatives, which are material information for investors and stakeholders.
The company reported strong financial results with significant growth in revenue, EBITDA, and PAT for Q4 and FY26. Expansion plans, strategic initiatives, and a strong balance sheet indicate a positive outlook.
Rainbow Children's Medicare Limited has released the transcript of its investor call held on May 25, 2026, concerning the financial results for the fourth quarter and the full fiscal year 2026. The call featured key management personnel including Dr. Ramesh Kancharla (Chairman and Managing Director), Mr. Abrarali Dalal (Group CEO), and Mr. Vikas Maheshwari (Group CFO).
During the call, Dr. Kancharla highlighted FY26 as a landmark year with the highest-ever annual capacity addition of nearly 500 beds, strengthening the company's long-term growth platform. He noted that investments made over the past two years are reflecting in performance, with Rainbow achieving its highest quarterly revenue and a 20% year-on-year growth. Key operating metrics like outpatient footfalls, inpatient discharges, and deliveries showed healthy growth. The company also saw seamless integration of acquired hospitals in Warangal and Guwahati, and positive patient traction in newly commissioned hospitals in Rajahmundry, Bangalore, and an IVF center. Rainbow was also recognized as a Great Place to Work for the sixth time.
Financially, for Q4 FY26, the company reported a revenue of ₹459.9 crore (a 24% growth), EBITDA of ₹144.7 crore (a 26% growth), and PAT of ₹78.2 crore (a 38% growth). For the full year FY26, revenues stood at ₹1,703 crore (12% growth), EBITDA at ₹544 crore (11% growth), and PAT at ₹282 crore (15.3% growth). The company is also expanding its project pipeline, with new hospitals planned in Coimbatore, Gurugram, Pune, Bangalore, Indore, and a joint venture for a pediatric and obstetrics service management in Indore.
Mr. Dalal emphasized the company's strong foundation and differentiated platform in women and children's healthcare, with a focus on improving occupancies, consultant engagement, and patient experience. He aims to drive a 20% growth in the current year while maintaining margins. Mr. Maheshwari detailed the financial performance, noting a strong balance sheet with ₹594 crore in liquidity and no debt. The company invested ₹217 crore in capex for FY26. Discussions also covered M&A strategies, focusing on scalable assets in attractive micro-markets across India and evaluating larger platforms. The company plans to share a more detailed growth plan in the next three months.
Regarding specific segments, IVF contributed 3.7% to total revenue for FY26 (₹61.4 crore), increasing quarterly. International patient revenue remained flat at approximately ₹28.9 crore. The company is working on standardizing quality across its network through the 'One Rainbow' initiative.
What to do with a filing like this
Rainbow Childrens Medicare Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Rainbow Childrens Medicare Limited. Read the original for the full detail.